Medidata Solutions Debt to Equity Ratio 2009-2018 | MDSO

Current and historical debt to equity ratio values for Medidata Solutions (MDSO) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Medidata Solutions debt/equity for the three months ending September 30, 2018 was 0.15.
Medidata Solutions Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-09-30 $0.09B $0.59B 0.15
2018-06-30 $0.09B $0.56B 0.16
2018-03-31 $0.09B $0.52B 0.18
2017-12-31 $0.09B $0.51B 0.18
2017-09-30 $0.00B $0.47B 0.00
2017-06-30 $0.27B $0.44B 0.61
2017-03-31 $0.27B $0.41B 0.65
2016-12-31 $0.26B $0.40B 0.66
2016-09-30 $0.26B $0.38B 0.69
2016-06-30 $0.26B $0.32B 0.82
2016-03-31 $0.25B $0.29B 0.86
2015-12-31 $0.25B $0.28B 0.88
2015-09-30 $0.25B $0.30B 0.83
2015-06-30 $0.25B $0.29B 0.86
2015-03-31 $0.24B $0.27B 0.90
2014-12-31 $0.24B $0.27B 0.91
2014-09-30 $0.24B $0.25B 0.96
2014-06-30 $0.24B $0.23B 1.00
2014-03-31 $0.23B $0.23B 1.03
2013-12-31 $0.23B $0.23B 1.02
2013-09-30 $0.23B $0.22B 1.05
2013-06-30 $0.00B $0.16B 0.00
2013-03-31 $0.00B $0.15B 0.00
2012-12-31 $0.00B $0.14B 0.00
2012-09-30 $0.00B $0.13B 0.00
2012-06-30 $0.00B $0.12B 0.00
2012-03-31 $0.00B $0.11B 0.00
2011-12-31 $0.00B $0.10B 0.00
2011-09-30 $0.00B $0.08B 0.00
2011-06-30 $0.00B $0.07B 0.00
2011-03-31 $0.00B $0.06B 0.00
2010-12-31 $0.00B $0.05B 0.00
2010-09-30 $0.00B $0.04B 0.01
2010-06-30 $0.00B $0.03B 0.01
2010-03-31 $0.00B $0.02B 0.02
2009-12-31 $0.00B $0.02B 0.04
2009-09-30 $0.00B $0.02B 0.06
2009-06-30 $0.01B $0.01B 0.96
2009-03-31 $0.00B $0.00B 0.00
2008-12-31 $0.00B $0.00B 0.00
2008-09-30 $0.00B $0.00B 0.00
2008-06-30 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $4.212B $0.546B
Medidata Solutions is a leading global provider of hosted clinical development solutions that enhance the efficiency of customers' clinical development processes and optimize their research and development investments. Medidata products and services allow customers to achieve clinical results more efficiently and effectively by streamlining the design, planning and management of key aspects of the clinical development process, including protocol development (Medidata Designer), investigator benchmarking and budgeting (Medidata Grants Manager), contract research organization (CRO) benchmarking and budgeting (Medidata CRO Contractor), and the capture, management, analysis and reporting of clinical trial data (Medidata Rave). Medidata's diverse customer base spans pharmaceutical, biotechnology and medical device companies, academic institutions, CROs and other research organizations, and includes some top global pharmaceutical companies.
Stock Name Country Market Cap PE Ratio
Cerner (CERN) United States $18.616B 26.04
Athenahealth (ATHN) United States $5.343B 36.45
HMS Holdings Corp (HMSY) United States $3.016B 46.67
Omnicell (OMCL) United States $2.742B 60.69
Allscripts Healthcare Solutions (MDRX) United States $1.730B 19.41
IRHYTHM TECH (IRTC) United States $1.644B 0.00
Tabula Rasa Healthcare (TRHC) United States $1.285B 179.40
Inspire Medical Systems (INSP) $1.027B 0.00
Quality Systems (NXGN) United States $0.976B 29.02
Invitae (NVTA) United States $0.904B 0.00
111 Sponsored ADR (YI) China $0.791B 0.00
Senseonics Holdings (SENS) United States $0.515B 0.00
AXONICS MODULTN (AXNX) United States $0.403B 0.00
Computer Programs And Systems (CPSI) United States $0.358B 14.42
NantHealth (NH) United States $0.152B 0.00
Strata Skin Sciences (SSKN) United States $0.076B 0.00
FULGENT GENETIC (FLGT) United States $0.064B 0.00
Motus GI Holdings (MOTS) United States $0.053B 0.00
Digirad (DRAD) United States $0.021B 0.00
Streamline Health Solutions (STRM) United States $0.017B 0.00
Transgenomic (PRPO) United States $0.007B 0.00